Pathologic re-review of NMIBC surgical specimens by genitourinary pathologists led to a change in risk stratification in one-fifth of cases. Pathologic re-review of transurethral resection of bladder ...
AURORA: A single arm, multicentre, phase II clinical trial of atezolizumab immunotherapy for advanced squamous cell carcinoma of the bladder and urinary tract. Sasanlimab in combination with bacillus ...
Cancers Symposium, and the updates were full of hope for people with advanced prostate cancer. CURE highlights two studies ...
More than 20 abstracts span Pfizer’s leading genitourinary cancer portfolio of approved standards of care and growing pipeline across prostate and bladder cancers Detailed overall survival (OS) ...
In a recent paper published in the American Journal of Clinical and Experimental Urology, researchers reviewed existing data on the effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV ...
Geography Should Not Be an “Oncologic Destiny” for Urothelial Cancer: Improving Access to Care by Removing Local, Regional, and International Barriers For more than a decade, advocates have urged ...
(UroToday.com) The 2026 GU ASCO annual meeting featured a kidney cancer trials in progress session and a presentation by Dr. Laurence Albiges discussing REJOICE-PanTumor01, a phase 2 signal-seeking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results